Title of article :
Prevention from Doxorubicin Cardiotoxicity by Available Protective Agents in Iran
Author/Authors :
Shahriari, M shiraz university of medical sciences - Department of Pediatrics, ايران , Abdolkarimi, B shiraz university of medical sciences - Department of Pediatrics, ايران
Abstract :
Doxorubicin, used in pediatric chemotherapy regimens, has cardiotoxic effects. Dexrazoxane is co- administrated with doxorubicin to prevent its cardiotoxicity. Here we have explored some alternative food or drugs to be used in absence of dexrazoxane since it’s not readily available in Iran at this time.
Keywords :
Pediatric , chemotherapy , doxorubicin , cardiotoxicity , dexrazoxane , Iran
Journal title :
Iranian Journal of Blood and Cancer (IJBC)
Journal title :
Iranian Journal of Blood and Cancer (IJBC)
